FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2897145170> ?p ?o ?g. }

• W2897145170 endingPage "1670" @default.
• W2897145170 startingPage "1670" @default.
• W2897145170 abstract "<h3>Importance</h3> Major warfarin-related bleeding occurs more frequently in African Americans than in other populations. Identification of potential genetic factors related to this adverse event may help identify at-risk patients. <h3>Objective</h3> To identify genetic factors associated with warfarin-related bleeding in patients of African descent at an international normalized ratio (INR) of less than 4. <h3>Design, Setting, and Participants</h3> A case-control genome-wide association study involving patients of African descent taking warfarin was conducted in a discovery cohort (University of Chicago [2009-2011] and the University of Illinois at Chicago [2002-2011]), and associations were confirmed in a replication cohort (University of Chicago [2015-2016]). Potential population stratification was examined in the discovery cohort by principal component analysis. Odds ratios (ORs) and 95% CIs were computed for bleeding risk by logistic regression analysis. Summary statistics from the discovery and the replication cohorts were analyzed with a fixed effects meta-analysis. The potential influence of single-nucleotide polymorphisms (SNPs) on gene expression was studied by luciferase expression assays. <h3>Exposures</h3> Single-nucleotide polymorphisms associated with warfarin-related bleeding. <h3>Main Outcomes and Measures</h3> Major bleeding—defined as bleeding requiring hospitalization, causing a decrease in hemoglobin level of more than 2 g/dL, requiring blood transfusion, or any combination of the 3—while taking warfarin at an INR of less than 4. <h3>Results</h3> The discovery cohort consisted of 31 cases (mean age, 60.1 years [SD, 14.9 years], 26 women [83.9%]) and 184 warfarin-treated controls (mean age, 57.1 years [SD, 15.7 years]) with no documented bleeding. The replication cohort consisted of 40 cases (mean age, 55.6 years [SD, 17.3 years], 27 women [67.5%]), and 148 warfarin-treated controls (mean age, 55.4 years [SD, 17.1 years]; 98 women [66.2%]) with no documented bleeding. In the discovery cohort, 4 SNPs in linkage disequilibrium on chromosome 6 (rs115112393,rs16871327,rs78132896, andrs114504854) were associated with warfarin-related bleeding but did not reach genome-wide significance. The SNPrs78132896occurred in 11 cases (35.5%) and 9 controls (4.9%) in the discovery cohort (OR, 8.31; 95% CI, 3.2-21.5;<i>P</i> < 6.21 × 10⁻⁸), and the association was confirmed in the replication cohort (the SNP was present in 14 cases [35.0%] and 7 controls [4.8%]; OR, 8.24; 95% CI, 3.1-25.3,<i>P</i> = 5.64 × 10⁻⁵). Genome-wide significance of this SNP was achieved when the cohorts were combined via meta-analysis (OR, 8.27; 95% CI, 4.18-16.38;<i>P</i> = 2.05 × 10⁻¹¹). These SNPs are found only in people of African descent. In vitro luciferase expression assays demonstrated thatrs16871327(enhancer SNP) andrs78132896(promoter SNP) risk alleles together increased<i>EPHA7</i>gene (Entrez Gene2045) transcription by a mean of 14.95 (SD, 1.7) compared with wild-type alleles (mean, 9.56 [SD, 0.84]; difference, 5.39; 95% CI, 4.1-6.6;<i>P</i> < .001). <h3>Conclusions and Relevance</h3> In this preliminary study involving patients of African descent taking warfarin, 4 single-nucleotide polymorphisms in linkage disequilibrium on chromosome 6 were associated with an increased risk of major bleeding at INR of less than 4. Validation of these findings in an independent prospective cohort is required." @default.
• W2897145170 created "2018-10-26" @default.
• W2897145170 creator A5022639503 @default.
• W2897145170 creator A5042916702 @default.
• W2897145170 creator A5049036783 @default.
• W2897145170 creator A5055189517 @default.
• W2897145170 creator A5055903336 @default.
• W2897145170 creator A5070710719 @default.
• W2897145170 creator A5077823193 @default.
• W2897145170 date "2018-10-23" @default.
• W2897145170 modified "2023-10-18" @default.
• W2897145170 title "Association of Genetic Variants With Warfarin-Associated Bleeding Among Patients of African Descent" @default.
• W2897145170 cites W159232318 @default.
• W2897145170 cites W1938992285 @default.
• W2897145170 cites W1964963969 @default.
• W2897145170 cites W1965740748 @default.
• W2897145170 cites W1967011539 @default.
• W2897145170 cites W1971362686 @default.
• W2897145170 cites W2016933463 @default.
• W2897145170 cites W2017538702 @default.
• W2897145170 cites W2018189081 @default.
• W2897145170 cites W2039500477 @default.
• W2897145170 cites W2040553983 @default.
• W2897145170 cites W2041822198 @default.
• W2897145170 cites W2054470297 @default.
• W2897145170 cites W2055850604 @default.
• W2897145170 cites W2065424213 @default.
• W2897145170 cites W2071276750 @default.
• W2897145170 cites W2084350813 @default.
• W2897145170 cites W2102776291 @default.
• W2897145170 cites W2111612576 @default.
• W2897145170 cites W2124416524 @default.
• W2897145170 cites W2127985968 @default.
• W2897145170 cites W2129271730 @default.
• W2897145170 cites W2133520037 @default.
• W2897145170 cites W2135625019 @default.
• W2897145170 cites W2163013660 @default.
• W2897145170 cites W2169092730 @default.
• W2897145170 cites W2171777347 @default.
• W2897145170 cites W2175065732 @default.
• W2897145170 cites W2408017125 @default.
• W2897145170 cites W2744350046 @default.
• W2897145170 cites W4232034913 @default.
• W2897145170 cites W4245749810 @default.
• W2897145170 doi "https://doi.org/10.1001/jama.2018.14955" @default.
• W2897145170 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6233811" @default.
• W2897145170 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30357299" @default.
• W2897145170 hasPublicationYear "2018" @default.
• W2897145170 type Work @default.
• W2897145170 sameAs 2897145170 @default.
• W2897145170 citedByCount "24" @default.
• W2897145170 countsByYear W28971451702018 @default.
• W2897145170 countsByYear W28971451702019 @default.
• W2897145170 countsByYear W28971451702020 @default.
• W2897145170 countsByYear W28971451702021 @default.
• W2897145170 countsByYear W28971451702022 @default.
• W2897145170 countsByYear W28971451702023 @default.
• W2897145170 crossrefType "journal-article" @default.
• W2897145170 hasAuthorship W2897145170A5022639503 @default.
• W2897145170 hasAuthorship W2897145170A5042916702 @default.
• W2897145170 hasAuthorship W2897145170A5049036783 @default.
• W2897145170 hasAuthorship W2897145170A5055189517 @default.
• W2897145170 hasAuthorship W2897145170A5055903336 @default.
• W2897145170 hasAuthorship W2897145170A5070710719 @default.
• W2897145170 hasAuthorship W2897145170A5077823193 @default.
• W2897145170 hasBestOaLocation W28971451701 @default.
• W2897145170 hasConcept C104317684 @default.
• W2897145170 hasConcept C126322002 @default.
• W2897145170 hasConcept C135763542 @default.
• W2897145170 hasConcept C151956035 @default.
• W2897145170 hasConcept C153209595 @default.
• W2897145170 hasConcept C156957248 @default.
• W2897145170 hasConcept C166976648 @default.
• W2897145170 hasConcept C201903717 @default.
• W2897145170 hasConcept C2776301958 @default.
• W2897145170 hasConcept C2779161974 @default.
• W2897145170 hasConcept C2908647359 @default.
• W2897145170 hasConcept C54355233 @default.
• W2897145170 hasConcept C71924100 @default.
• W2897145170 hasConcept C72563966 @default.
• W2897145170 hasConcept C86803240 @default.
• W2897145170 hasConcept C99454951 @default.
• W2897145170 hasConceptScore W2897145170C104317684 @default.
• W2897145170 hasConceptScore W2897145170C126322002 @default.
• W2897145170 hasConceptScore W2897145170C135763542 @default.
• W2897145170 hasConceptScore W2897145170C151956035 @default.
• W2897145170 hasConceptScore W2897145170C153209595 @default.
• W2897145170 hasConceptScore W2897145170C156957248 @default.
• W2897145170 hasConceptScore W2897145170C166976648 @default.
• W2897145170 hasConceptScore W2897145170C201903717 @default.
• W2897145170 hasConceptScore W2897145170C2776301958 @default.
• W2897145170 hasConceptScore W2897145170C2779161974 @default.
• W2897145170 hasConceptScore W2897145170C2908647359 @default.
• W2897145170 hasConceptScore W2897145170C54355233 @default.
• W2897145170 hasConceptScore W2897145170C71924100 @default.
• W2897145170 hasConceptScore W2897145170C72563966 @default.
• W2897145170 hasConceptScore W2897145170C86803240 @default.
• W2897145170 hasConceptScore W2897145170C99454951 @default.

• next